Alterations in Faecal Metagenomics and Serum Metabolomics Indicate Management Strategies for Patients With Budd-Chiari Syndrome

Alterations in Faecal Metagenomics and Serum Metabolomics Indicate Management Strategies for Patients With Budd-Chiari Syndrome

We investigated the effects of gut microbiota and serum metabolite levels in patients with Budd-Chiari syndrome (B-CS) and their importance for guiding clinical management strategies. In total, 214 B-CS patients (93 untreated and 121 treated) and 41 healthy controls were enrolled. Gut microbiota and...

Full description

Bibliographic Details
Main Authors: Qinwei Lu, Hao Xu, Lin Zhou, Ruifang Zhang, Zhen Li, Peng Xu, Tao Bai, Zhiwei Wang, Gang Wu, Jianzhuang Ren, Dechao Jiao, Yan Song, Rongtao Zhu, Jian Li, Weijie Wang, Ruopeng Liang, Lin Li, Xiuxian Ma, Maoheng Zu, Yuling Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Budd-Chiari syndrome
gut microbiota
metagenomics
metabolomics
management strategies
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.730091/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2021.730091/full

Similar Items